TJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Software (PMTA)

TJP Labs Inc. Receives FDA Acceptance For Premarket Tobacco Product Software (PMTA)

PICKERING, ON, Jan. 13, 2023 /CNW/ – TJP Labs Inc. (“TJP Labs”) is proud to announce the acceptance of its Premarket Tobacco Product Software (PMTA) submission by the U.S. Meals and Drug Administration for its model, L!X nicotine pouches. 

Marketed by its subsidiary L!X Improvements Inc. (“L!X Improvements”) underneath the identify L!X nicotine pouches, the model’s software strikes ahead to the subsequent step within the PMTA assessment course of.

Talking on the event, David Richmond-Peck, CEO of TJP Labs, stated: 

“TJP Labs created L!X nicotine pouches for grownup (21+) customers of nicotine-containing merchandise who can not or select to not discontinue nicotine use, particularly those that want to transition to non-combustible, oral-use merchandise. The acceptance of our software by the FDA showcases our crew’s dedication to offering grownup customers with options that may probably cut back the hurt related to conventional flamable tobacco merchandise.

Our facility’s Well being Canada Drug Institution License (DEL), Pure Well being Merchandise Web site-License, ISO 9001:2015, HACCP and cGMP certifications converse to the rigorous high quality requirements at TJP Labs and can additional bolster our skill to service high-volume worldwide markets.”

About TJP Labs Inc. 

TJP Labs Inc. is North America’s main full-service contract producer of premier next-generation merchandise, specializing in fashionable oral nicotine pouches and oral supply options for caffeine and different nutraceutical merchandise. 

Our merchandise are manufactured and packaged in our DEL, NHP Web site-Licensed, cGMP/HACCP compliant, ISO 9001:2015 licensed state-of-the-art services.

Web site:


For additional info: TJP Labs Inc., [email protected]